keyword
https://read.qxmd.com/read/38460072/long-term-complications-of-permanent-hypoparathyroidism-in-adults-prevalence-and-associated-factors
#1
JOURNAL ARTICLE
Faten Cherchir, Ibtissem Oueslati, Meriem Yazidi, Fatma Chaker, Habiba Mizouni, Moncef Feki, Melika Chihaoui
INTRODUCTION: Patients with Chronic hypoparathyroidism (CHPT) receiving conventional treatment are exposed to several long-term complications including basal ganglia calcifications, posterior subcapsular cataract, kidney stones, and renal insufficiency. The aim of this study was to assess the prevalence and the associated factors of these complications in patients with CHPT. METHODS: We conducted a cross-sectional study including 58 patients with CHPT. All participants underwent physical examination, biochemical assessment (total serum calcium, serum phosphorus, serum albumin, intact-PTH, serum magnesium, 25-hydroxy-vitamin D, serum creatinine, thyroid stimulating hormone (TSH), and 24-hour urinary calcium), slit lamp examination, brain computed tomography scan (CT-scan), and renal ultrasound...
March 9, 2024: Endocrine
https://read.qxmd.com/read/38441788/jam2-variants-can-be-more-common-in-primary-familial-brain-calcification-pfbc-cases-than-those-appear-may-be-due-to-a-founder-mutation
#2
JOURNAL ARTICLE
Mana Khojasteh, Parsa Soleimani, Aida Ghasemi, Peyman Taghizadeh, Mohammad Rohani, Afagh Alavi
INTRODUCTION: Mutations in JAM2 have been linked to ~ 2% of primary familial brain calcification (PFBC) cases. PFBC is a rare neurological disorder characterized by excessive calcium deposition in the brain. It causes movement disorders and psychiatric problems. Six other genes were identified as causing PFBC. However, the genetic basis of ~ 50% of PFBC cases remains unknown. This study presented the results of a comprehensive analysis of five unrelated Iranian PFBC families...
March 5, 2024: Neurological Sciences
https://read.qxmd.com/read/38337525/the-association-between-intracranial-calcifications-and-symptoms-in-patients-with-primary-familial-brain-calcification
#3
JOURNAL ARTICLE
Gini Mathijssen, Evelien van Valen, Pim A de Jong, Nienke M S Golüke, Emiel A van Maren, Birgitta M G Snijders, Eva H Brilstra, Ynte M Ruigrok, Susan Bakker, Renzo W Goto, Marielle H Emmelot-Vonk, Huiberdina L Koek
(1) Background: Primary Familial Brain Calcification (PFBC) is a neurodegenerative disease characterized by bilateral calcifications of the basal ganglia and other intracranial areas. Many patients experience symptoms of motor dysfunction and cognitive disorders. The aim of this study was to investigate the association between the amount and location of intracranial calcifications with these symptoms. (2) Methods: Patients with suspected PFBC referred to our outpatient clinic underwent a clinical work-up. Intracranial calcifications were visualized on Computed Tomography (CT), and a Total Calcification Score (TCS) was constructed...
January 31, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38333236/rare-case-in-somalia-fahr-s-syndrome
#4
Aisha M Adam, Omar A Sheikh, Miski A Roble, Mehmet Z Yaşar, Shukri S Mohamed, Mohamed M Kassim
INTRODUCTION AND IMPORTANCE: Fahr's syndrome is primarily familial, autosomal dominant, and genetically diverse. Basal ganglia calcification that is bilaterally symmetrical is a hallmark of this illness. Although the specific origins of this illness are unknown, it may be brought on by problems with calcium metabolism, infections, toxins, hereditary factors, hypoparathyroidism, and pseudohypoparathyroidism. The prevalence of this syndrome is less than 0.5%. CASE PRESENTATION: An 11-year-old female comes to the Emergency Department with her parents complaining of high-grade fever and convulsions for 1 week...
February 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38326858/the-effects-of-etidronate-on-brain-calcifications-in-fahr-s-disease-or-syndrome-rationale-and-design-of-the-randomised-placebo-controlled-double-blind-calcifade-trial
#5
RANDOMIZED CONTROLLED TRIAL
Birgitta Mg Snijders, Gini Mathijssen, Mike Jl Peters, Marielle H Emmelot-Vonk, Pim A de Jong, Susan Bakker, Heleen A Crommelin, Ynte M Ruigrok, Eva H Brilstra, Vera Pm Schepers, Wilko Spiering, Evelien van Valen, Huiberdina L Koek
BACKGROUND: Fahr's disease and syndrome are rare disorders leading to calcification of the small arteries in the basal ganglia of the brain, resulting in a wide range of symptoms comprising cognitive decline, movement disorders and neuropsychiatric symptoms. No disease-modifying therapies are available. Studies have shown the potential of treatment of ectopic vascular calcifications with bisphosphonates. This paper describes the rationale and design of the CALCIFADE trial which evaluates the effects of etidronate in patients with Fahr's disease or syndrome...
February 7, 2024: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/38314389/basal-ganglia-calcification-a-case-report-of-two-siblings-with-fahr-s-disease
#6
Margarida Magalhães, Margarida Alves, Luís Paulino Ferreira, Janice Alves, Diana Durães
Fahr's disease is a rare neurodegenerative disorder caused by bilateral and usually symmetrical intracranial calcifications. In most cases, it exhibits an autosomal dominant pattern of inheritance and genetic heterogeneity. Patients may present with movement disorders, cognitive impairment, and psychiatric disorders. Currently, there are no disease-modifying drugs, so the management is based on the treatment of the symptoms. We present two cases involving male siblings, both with psychiatric symptoms as the initial presentation of the disease...
February 2024: Curēus
https://read.qxmd.com/read/38306416/response-to-tumor-infiltrating-lymphocyte-adoptive-therapy-is-associated-with-preexisting-cd8-t-myeloid-cell-networks-in-melanoma
#7
JOURNAL ARTICLE
David Barras, Eleonora Ghisoni, Johanna Chiffelle, Angela Orcurto, Julien Dagher, Noémie Fahr, Fabrizio Benedetti, Isaac Crespo, Alizée J Grimm, Matteo Morotti, Stefan Zimmermann, Rafael Duran, Martina Imbimbo, Maria Ochoa de Olza, Blanca Navarro, Krisztian Homicsko, Sara Bobisse, Danny Labes, Zoe Tsourti, Charitini Andriakopoulou, Fernanda Herrera, Rémy Pétremand, Reinhard Dummer, Gregoire Berthod, Anne I Kraemer, Florian Huber, Jonathan Thevenet, Michal Bassani-Sternberg, Niklaus Schaefer, John O Prior, Maurice Matter, Veronica Aedo, Clarisse Dromain, Jesus Corria-Osorio, Stéphanie Tissot, Lana E Kandalaft, Raphael Gottardo, Mikaël Pittet, Christine Sempoux, Olivier Michielin, Urania Dafni, Lionel Trueb, Alexandre Harari, Denarda Dangaj Laniti, George Coukos
Adoptive cell therapy (ACT) using ex vivo-expanded tumor-infiltrating lymphocytes (TILs) can eliminate or shrink metastatic melanoma, but its long-term efficacy remains limited to a fraction of patients. Using longitudinal samples from 13 patients with metastatic melanoma treated with TIL-ACT in a phase 1 clinical study, we interrogated cellular states within the tumor microenvironment (TME) and their interactions. We performed bulk and single-cell RNA sequencing, whole-exome sequencing, and spatial proteomic analyses in pre- and post-ACT tumor tissues, finding that ACT responders exhibited higher basal tumor cell-intrinsic immunogenicity and mutational burden...
February 2, 2024: Science Immunology
https://read.qxmd.com/read/38298377/editorial-endocrine-disruptors-and-diseases-of-brain-and-mind-past-and-prelude
#8
EDITORIAL
Ashu Johri, Luca Roncati, Fernando Lizcano
No abstract text is available yet for this article.
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38296507/fahr-s-disease-in-a-patient-with-recurrent-pneumonias-parkinsonism-and-dementia
#9
JOURNAL ARTICLE
Christopher Jude Pinto, Harshita Agrawal, Holly Schmidt, Layth Tumah
Fahr's disease is a rare condition characterised by the presence of idiopathic familial bilateral basal ganglia calcifications, transmitted in an autosomal-dominant fashion. Diagnosis is based on clinical features of neuropsychiatric and somatic symptoms in conjunction with radiological findings. Our patient, a man in his early 50s, presented with pneumonia. History was significant for five admissions in the last 2 years for pneumonia and falls, with gradual cognitive and motor decline since his late 30s. Hypophonia, bradykinesia and dementia were noted on examination...
January 31, 2024: BMJ Case Reports
https://read.qxmd.com/read/38292780/fahr-syndrome-and-neurological-manifestations-in-hypoparathyroidism-patients
#10
Vincentius Diamantino Supit, Dedy Kurniawan, Ersifa Fatimah
Fahr syndrome is an uncommon (prevalence < 1/1.000.000) neurological disorder characterized by abnormal calcified deposits in the basal ganglia, nucleus dentatus, and cerebral cortex. These calcification can lead to various neurological manifestations. Distinguishing Fahr syndrome from Fahr disease is crucial due to differences in their etiology, location of lesions, prognosis, and therapy. Currently, Fahr disease lacks a specific treatment, while Fahr syndrome requires target intervention based on the underlying cause...
April 2024: Radiology Case Reports
https://read.qxmd.com/read/38274621/retraction-fahr-disease-a-rare-cause-of-first-time-seizure-in-the-emergency-department
#11
Faleh M Aldawsari, Turki B Alotaibi, Omran S Hashim, Zainab A Bu Hamad, Maha R Eisaa, Abdulrahman A Alhumaidi, Salem M Alanazi, Fahad F Alenezi, Afnan A Batwie, Abdulaziz A Habib, Sukainah S Alismail, Omar S Almulhim, Abdullah F Al Amer, Thamer A Alghamdi, Faisal Al-Hawaj
[This retracts the article DOI: 10.7759/cureus.19965.].
January 2024: Curēus
https://read.qxmd.com/read/38269217/a-case-report-of-fahr-s-disease-and-its-clinical-heterogeneity
#12
Shraddha Adhikari, Archana Bhate, Smita Patil, Mihit Kalawatia, Ravi Sangoi, Amisha Palande, Parijat Kamble, Gaurav Mittal
Fahr's disease is an exceptionally rare and complex neurological disorder characterized by abnormal calcium deposition in the basal ganglia and cerebral cortex. This case report presents a 27-year-old female with Fahr's disease, showcasing the striking clinical diversity and challenging diagnostic landscape associated with this condition. Despite its rarity, Fahr's disease can have a profound impact on patients, manifesting as a spectrum of neurological symptoms, cognitive deficits, and motor impairment. Recent advancements in research have illuminated genetic aspects, offering potential avenues for enhanced diagnostic accuracy and therapeutic interventions...
December 2023: Curēus
https://read.qxmd.com/read/38240084/altered-histone-acetylation-patterns-in-pancreatic-cancer-cell-lines-induce-subtype%C3%A2-specific-transcriptomic-and-phenotypical-changes
#13
JOURNAL ARTICLE
Quan Zhou, Svenja Pichlmeier, Anna Maria Denz, Nicole Schreiner, Tobias Straub, Simone Benitz, Julia Wolff, Lisa Fahr, Maria Del Socorro Escobar Lopez, Jörg Kleeff, Julia Mayerle, Ujjwal Mukund Mahajan, Ivonne Regel
Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed at advanced tumor stages with chemotherapy as the only treatment option. Transcriptomic analysis has defined a classical and basal‑like PDAC subtype, which are regulated by epigenetic modification. The present study aimed to determine if drug‑induced epigenetic reprogramming of pancreatic cancer cells affects PDAC subtype identity and chemosensitivity. Classical and basal‑like PDAC cell lines PaTu‑S, Capan‑1, Capan‑2, Colo357, PaTu‑T, PANC‑1 and MIAPaCa‑2, were treated for a short (up to 96 h) and long (up to 30 weeks) period with histone acetyltransferase (HAT) and histone deacetylase (HDAC) inhibitors...
March 2024: International Journal of Oncology
https://read.qxmd.com/read/38226128/fahr-syndrome-when-dysarthria-doesn-t-mean-a-stroke
#14
Daniela Casanova, Ana L Ferreira, Ana Sá, Isabel Trindade, Jorge Cotter
Fahr syndrome is a rare neurodegenerative disorder, characterized by calcium deposition in the brain. It is usually associated with phosphocalcium metabolism disorders, like hypoparathyroidism, or with genetical predisposition, as seen in Fahr disease. Given the wide array of differential diagnoses medical awareness should be emphasized to prompt diagnosis and management. In this case, we depict a classical presentation of Fahr syndrome, highlighting the differential diagnosis with stroke given the similar clinical signs and symptoms, although pointing out the distinct radiological presentation that raises clinical suspicion for this entity...
December 2023: Curēus
https://read.qxmd.com/read/38159019/-neurological-manifestations-of-hypoparathyroidism-diagnostic-difficulties-case-report
#15
JOURNAL ARTICLE
E P Nuzhnyi, K V Antonova, M M Tanashyan, S N Illarioshkin
Hypoparathyroidism is a rare condition characterized by reduced production of parathyroid hormone or tissue resistance which leads to hypocalcemia and hyperphosphatemia. Neurological manifestations often occur as the first symptoms of hypoparathyroidism and are characterized by a wide variety of symptoms of both the central and peripheral nervous systems dysfunction, which requires a differential diagnosis with a wide range of neurological diseases. Two clinical cases illustrating the features of subacute and chronic hypoparathyroidism are presented...
November 23, 2023: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/38144999/parasocial-interactions-with-media-characters-the-role-of-perceived-and-actual-sociodemographic-and-psychological-similarity
#16
JOURNAL ARTICLE
Michelle Möri, Andreas Fahr
INTRODUCTION: Similarity between media character and viewer is an important predictor of parasocial interactions. Thereby, similarities are often limited to single characteristics or to the similarities viewers perceive between themselves and characters. This article expands the existing literature in two ways. First, the effects of actual and perceived similarity on parasocial interactions are compared. Second, similarity is understood in a broad way. With age, gender, job, relationship, and living situation are assessed for sociodemographic similarities...
2023: Frontiers in Psychology
https://read.qxmd.com/read/38103079/sustainable-trehalose-lipid-production-by-rhodotorula-sp-a-promising-bio-based-alternative
#17
JOURNAL ARTICLE
Sara Lopes, Eva Fahr, João Costa, Andreia B Silva, M Manuel Lopes, Célia Faustino, Maria H L Ribeiro
Global environmental concerns drive research toward the development of new eco-friendly compounds to replace pollutant chemicals. This study focuses on optimizing the production of trehalose lipids (TLs), which are glycolipid biosurfactants (BS) with various applications like antimicrobial or surface tension reduction. New microorganism sources, growth conditions, medium composition, purification conditions, and physicochemical properties of TLs are studied. Addressing a microscale approach, TLs production was successfully achieved using Rhodotorula sp...
December 16, 2023: Bioprocess and Biosystems Engineering
https://read.qxmd.com/read/38097569/psilocybin-induced-default-mode-network-hypoconnectivity-is-blunted-in-alcohol-dependent-rats
#18
JOURNAL ARTICLE
Jonathan R Reinwald, Christian N Schmitz, Ivan Skorodumov, Martin Kuchar, Wolfgang Weber-Fahr, Rainer Spanagel, Marcus W Meinhardt
Alcohol Use Disorder (AUD) adversely affects the lives of millions of people, but still lacks effective treatment options. Recent advancements in psychedelic research suggest psilocybin to be potentially efficacious for AUD. However, major knowledge gaps remain regarding (1) psilocybin's general mode of action and (2) AUD-specific alterations of responsivity to psilocybin treatment in the brain that are crucial for treatment development. Here, we conducted a randomized, placebo-controlled crossover pharmaco-fMRI study on psilocybin effects using a translational approach with healthy rats and a rat model of alcohol relapse...
December 14, 2023: Translational Psychiatry
https://read.qxmd.com/read/38045865/fahr-syndrome-secondary-to-pseudohypoparathyroidism
#19
Sharon W Shu, Sakshi Sharma, Qasim Z Iqbal, Karina G Romo
Fahr syndrome is a rare neurologic disorder, usually affecting young and middle-aged adults, that can present with symptoms ranging from extrapyramidal to neuropsychiatric abnormalities. Pseudohypoparathyroidism (PHP), characterized by parathyroid hormone (PTH)-resistance or PTH-unresponsiveness at target organs, is associated with Fahr syndrome and typically presents with hypocalcemia. The following case presents a 39-year-old-woman with PHP complicated by symptomatic hypocalcemia, hypokalemia, and movement disturbances, who had computed tomography imaging showing basal ganglia calcifications consistent with Fahr syndrome...
November 2023: JCEM Case Rep
https://read.qxmd.com/read/38022014/fahr-s-syndrome-a-rare-case-presentation
#20
Muhammad Hayyan Wazir, Yamna Ali, Ahmad Z Mufti, Alvina Ahmad, Hasnain Ahmad
Idiopathic basal ganglia calcification (IBGC), also known as Fahr's disease, is a rare neurological disorder characterized by metabolic, biochemical, neuroradiological, and neuropsychiatric alterations resulting from symmetrical and bilateral intracranial calcifications. In most cases, an autosomal dominant pattern of inheritance and genetic heterogeneity is observed. Neuropsychiatric symptoms with movement disorders account for 55% of the manifestations of this disease. In this report, we present the case of a 42-year-old Pakistani male who presented to the emergency department with a sudden onset of generalized tonic muscle contractions...
October 2023: Curēus
keyword
keyword
65723
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.